Schmidt MK

ORCID: 0000-0002-2228-429X · 2 papers in corpus

2016

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

Gynecologic Oncology ·doi:10.1016/j.ygyno.2015.04.034

ObjectiveClinical genetic testing is commercially available for rs61764370, an inherited variant residing in a KRAS 3' UTR microRNA binding site, based on suggested associations with increased ovarian and breast cancer risk as well as with …

2013

Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies.

Current drug safety ·doi:10.2174/15680266113136660067

BackgroundAn association of insulin use and risk of cancer has been reported but evidence is conflicting and methodological issues have been identified.ObjectiveTo summarize results regarding insulin use and cancer risk by a systematic revi…